What happened, in summary

Nicole was 42 and working as a fine jewelry designer when a sharp seatbelt-like pain across her chest led her to feel a new breast change. Because she had dense, fibrous breast tissue and a history of cysts, a cyst seemed possible, but her gynecologist was concerned during the exam and pushed for a rushed diagnostic mammogram. Nicole had to advocate for herself because she was young for breast cancer screening. Biopsy and staging showed triple-negative breast cancer. A PET scan then revealed that the cancer had already spread to her liver, making it Stage IV. Nicole asked her oncologist not to give her a timeline because she wanted to stay hopeful. Her first treatment was chemotherapy, but after about 2 months the breast tumor was still growing, her lymph nodes were enlarged, and she developed infection-related symptoms. Her oncologist changed the plan to an antibody-drug conjugate, described as targeted chemotherapy. That treatment finally shrank the tumor enough for surgery. Nicole later had a mastectomy with flat closure because reconstruction would have required too much time off chemotherapy. As of October 2025, she was continuing treatment, using jewelry design as a grounding practice, and advocating for younger breast cancer patients to trust their instincts.